RNA modifications shape gut immunity and intestinal macrophage function

A new perspective on gut immunity is highlighting the powerful role of RNA modifications in shaping how the body maintains balance in the digestive system. At the center of this emerging view are intestinal macrophages, highly adaptable immune cells that act as guardians of the gut, protecting against harmful invaders while preserving harmony with beneficial microbes.

These cells operate in one of the body's most complex environments, where they must continuously interpret signals from microbiota, surrounding tissues, and dietary inputs. Their ability to respond appropriately depends on remarkable cellular plasticity, allowing them to shift between pro-inflammatory and anti-inflammatory states as conditions change. This flexibility is now understood to be tightly controlled by epitranscriptomic regulation, a process that modifies RNA to influence how genes are expressed.

Key to this regulation are chemical changes to RNA, including m6A, m1A, and m5C modifications. These molecular adjustments act as precise control points, determining how macrophages develop, function, and communicate. By influencing processes such as cytokine production, metabolic activity, and tissue repair, RNA modifications enable immune cells to rapidly adapt to their surroundings.

The significance of these mechanisms becomes especially clear in the context of disease. When RNA modification pathways are disrupted, macrophages can become imbalanced, leading to excessive inflammation or impaired healing. Such dysfunction is closely linked to conditions like inflammatory bowel disease and colorectal cancer, where immune responses fail to resolve properly and instead contribute to ongoing tissue damage.

The gut microenvironment plays a crucial role in shaping these outcomes. Signals from the microbiome, including metabolites and microbial byproducts, directly influence the enzymes responsible for adding or removing RNA modifications. This creates a dynamic feedback system in which environmental factors and immune responses are tightly interconnected.

Equally important are the interactions between macrophages and neighboring cells. Close communication with intestinal epithelial cells, stromal cells, and the enteric nervous system ensures coordinated responses that maintain barrier integrity and support regeneration. RNA modifications help regulate these interactions, fine-tuning immune activity to match the needs of the tissue.

This evolving understanding opens the door to innovative therapeutic strategies. By targeting RNA modification pathways, it may be possible to reprogram immune responses, reduce harmful inflammation, and restore balance in the gut. Such approaches represent a promising direction for treating complex intestinal disorders.

As knowledge in this area continues to expand, RNA modifications are emerging as a central mechanism linking immunity, inflammation, and the gut environment, offering new possibilities for precision medicine in digestive health.

Source:
Journal reference:

Manqiqige Su, Jiyuan Fan, Hua-Bing Li, RNA modifications in intestinal macrophages: Implications for gut immunity and inflammation, Genes & Diseases, Volume 13, Issue 2, 2026, 101881, https://doi.org/10.1016/j.gendis.2025.101881

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Single-cell sequencing reveals why some CAR-T therapies succeed while others fail